2022 Revenues ($USD) : $993,196,000
2022 R&D spend : $46,801,000
2022 Number of Employees : 2,821
Fiscal Year End : 4/2/2022
Company CEO : Christopher Simon, CEO and president

Haemonetics technologies serve medical markets including blood and plasma component collection, the surgical suite and hospital transfusion. The Boston-based company’s first-quarter results highlighted significant growth as revenues were up 14.4%, with plasma collection increasing by 42.5% year-over-year. Haemonetics also announced in June that it fully commenced operations at its new manufacturing center in Clinton, Pennsylvania. –SW